Similar articles

• The metabolic toxicities of antiretroviral therapy.

  Herman JS, Easterbrook PJ. Herman JS, et al. Int J STD AIDS. 2001 Sep;12(9):555-62; quiz 563-4. doi: 10.1258/0956462011923714. Int J STD AIDS. 2001. PMID: 11516363 Review.
• Metabolic complications associated with the use of highly active antiretroviral therapy in HIV-1-infected adults.

  Monier PL, Wilcox R. Monier PL, et al. Am J Med Sci. 2004 Jul;328(1):48-56. doi: 10.1097/00000441-200407000-00007. Am J Med Sci. 2004. PMID: 15254441
• Metabolic and hepatobiliary side effects of antiretroviral therapy (ART).

  Lugassy DM, Farmer BM, Nelson LS. Lugassy DM, et al. Emerg Med Clin North Am. 2010 May;28(2):409-19, Table of Contents. doi: 10.1016/j.emc.2010.01.011. Emerg Med Clin North Am. 2010. PMID: 20413022
• Symptomatic hyperlactataemia and lactic acidosis in the era of highly active antiretroviral therapy.

  Eshun-Wilson I, Soentjens P, Zeier M, Taljaard J. Eshun-Wilson I, et al. S Afr Med J. 2005 Dec;95(12):929-30. S Afr Med J. 2005. PMID: 16465351 Review. No abstract available.
• [Metabolic disorders associated with HIV and antiretroviral therapy].

  Roca B. Roca B. An Med Interna. 2003 Nov;20(11):585-93. An Med Interna. 2003. PMID: 14624657 Review. Spanish.